Literature DB >> 19232278

Functional heartburn: what it is and how to treat it.

Ronnie Fass1.   

Abstract

Functional heartburn is considered one of the most common functional esophageal disorders. The disorder is more common in young women and is associated with other functional bowel disorders and psychological co-morbidity, primarily somatization. The etiology of functional heartburn remains unknown. Most patients, however, demonstrate esophageal hypersensitivity. Functional heartburn has been identified as the main cause for proton pump inhibitor (PPI) failure in patients with heartburn. Treatment is still a challenge, and patients should be started with PPI treatment. In non-responders, escalation of the PPI dose could be attempted and, if unsuccessful, pain modulators should be prescribed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19232278     DOI: 10.1016/j.giec.2008.12.002

Source DB:  PubMed          Journal:  Gastrointest Endosc Clin N Am        ISSN: 1052-5157


  10 in total

1.  Psychological Comorbidity and Chronic Heartburn: Which Is the Chicken and Which Is the Egg?

Authors:  Ronnie Fass; Shira S Fass
Journal:  Dig Dis Sci       Date:  2017-02-15       Impact factor: 3.199

2.  Functional heartburn.

Authors:  Ronnie Fass
Journal:  Gastroenterol Hepatol (N Y)       Date:  2014-06

3.  Gastroesophageal reflux symptoms not responding to proton pump inhibitor: GERD, NERD, NARD, esophageal hypersensitivity or dyspepsia?

Authors:  Mohammad Bashashati; Reza A Hejazi; Christopher N Andrews; Martin A Storr
Journal:  Can J Gastroenterol Hepatol       Date:  2014-04-09

Review 4.  New therapies for non-cardiac chest pain.

Authors:  Carla Maradey-Romero; Ronnie Fass
Journal:  Curr Gastroenterol Rep       Date:  2014

5.  Update on Functional Heartburn.

Authors:  Takahisa Yamasaki; Jessica O'Neil; Ronnie Fass
Journal:  Gastroenterol Hepatol (N Y)       Date:  2017-12

6.  Structured management strategy based on the Gastro-oesophageal Reflux Disease (GERD) Questionnaire (GerdQ) vs. usual primary care for GERD: pooled analysis of five cluster-randomised European studies.

Authors:  J Ponce; V Garrigues; L Agréus; E Tabaglio; M Gschwantler; E Guallar; M Tafalla; J Nuevo; J Hatlebakk
Journal:  Int J Clin Pract       Date:  2012-07-16       Impact factor: 2.503

7.  The Proton Pump Inhibitor Non-Responder: A Clinical Conundrum.

Authors:  Zilla H Hussain; Emily E Henderson; Carla Maradey-Romerao; Nina George; Ronnie Fass; Brian E Lacy
Journal:  Clin Transl Gastroenterol       Date:  2015-08-13       Impact factor: 4.488

Review 8.  New and future drug development for gastroesophageal reflux disease.

Authors:  Carla Maradey-Romero; Ronnie Fass
Journal:  J Neurogastroenterol Motil       Date:  2013-12-30       Impact factor: 4.924

Review 9.  Clinical potential of eluxadoline in the treatment of diarrhea-predominant irritable bowel syndrome.

Authors:  Aleksandra Sobolewska-Włodarczyk; Marcin Włodarczyk; Martin Storr; Jakub Fichna
Journal:  Ther Clin Risk Manag       Date:  2016-05-13       Impact factor: 2.423

10.  Decreased Plasma BDNF Levels of Patients with Somatization Disorder.

Authors:  Nam-In Kang; Jong-Il Park; Yong-Ku Kim; Jong-Chul Yang
Journal:  Psychiatry Investig       Date:  2016-09-30       Impact factor: 2.505

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.